Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of American Academy of Dermatology

• Publication date

  1998-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0190-9622(98)70490-6PMID 9631989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Onychomycosis--more than a cosmetic problem].

  1999cited by this paper
• Treatment of toenail onychomycosis

  1999cited by this paper
• Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail.

  1998cited by this paper
• Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study.

  1996cited by this paper
• Diagnosing and treating onychomycosis.

  1996cited by this paper
• New therapies for onychomycosis.

  1996cited by this paper
• Onychomycosis: a significant medical disorder.

  1996cited by this paper
• FLUCONAZOLE IN THE TREATMENT OF SEVERE ONYCHOMYCOSIS

  1996cited by this paper
• Comparison of the in vitro activity of fluconazole against Candida albicans and dermatophytes.

  1995cited by this paper
• An evaluation of the safety and efficacy of fluconazole in the treatment of onychomycosis.

  1995cited by this paper
• Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group.

  1995cited by this paper
• Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin.

  1995cited by this paper
• New approaches to the diagnosis and management of onychomycosis. International Symposium, Monaco, April 1-2, 1993.

  1994cited by this paper
• Mycology of nail disorders.

  1994cited by this paper
• PROCEEDINGS AND TRANSACTIONS

  1994cited by this paper
• The in vitro activity of fluconazole against fungi involved in dermal infections

  1994cited by this paper
• The efficacy of orally applied terbinafine, itraconazole and fluconazole in models of experimental trichophytoses.

  1994cited by this paper
• FLUCONAZOLE VERSUS KETOCONAZOLE IN THE TREATMENT OF DERMATOPHYTOSES AND CUTANEOUS CANDIDIASIS

  1994cited by this paper
• Onychomycosis is more than a cosmetic problem

  1994cited by this paper
• Antifungal agents: an overview. Part II.

  1994cited by this paper
• Risk/benefit ratio of modern antifungal therapy: focus on hepatic reactions.

  1993cited by this paper
• Levels of fluconazole in serum, stratum corneum, epidermis‐dermis (without stratum corneum) and eccrine sweat

  1993cited by this paper
• Onychomycosis. Agents of choice.

  1993cited by this paper
• What constitutes a "cure" in lymphoma?

  1993cited by this paper
• Antifungal susceptibility testing

  1993cited by this paper
• Onychomycosis: successful treatment with once-weekly fluconazole.

  1993cited by this paper
• Terbinafine Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Superficial Mycoses

  1992cited by this paper
• Recalcitrant onychomycosis of the toenails successfully treated with fluconazole.

  1992cited by this paper
• Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin.

  1992cited by this paper
• Efficacy and safety of itraconazole in the long-term treatment of onychomycosis.

  1992cited by this paper
• Clinical and mycological diagnostic aspects of onychomycoses and dermatomycoses

  1992cited by this paper
• ANIMAL MODELS FOR TESTING TOPICAL CORTICOSTEROID POTENCY: A REVIEW AND SOME SUGGESTED NEW APPROACHES

  1992cited by this paper
• Fluconazole in the treatment of onychomycosis caused by dermatophytes

  1992cited by this paper
• Clinical manifestations of onychomycosis

  1992cited by this paper
• Onychomycosis Treated with Itraconazole or Griseofulvin Alone with and without a Topical Antimycotic or Keratolytic Agent

  1991cited by this paper
• Nails: Therapy, Diagnosis, Surgery

  1990cited by this paper
• Pharmacokinetics and tissue penetration of fluconazole in humans.

  1990cited by this paper
• [Treatment of fungal infections of the skin].

  1989cited by this paper
• An evaluation of itraconazole in the management of onychomycosis

  1988cited by this paper
• A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis

  1985cited by this paper
• Onychomycosis

  1983cited by this paper
• Mycological and Clinical Evaluation of Griseofulvin for Chronic Onychomycosis

  1967cited by this paper

• Combatting antifungal resistance: Paradigm shift in the diagnosis and management of onychomycosis and dermatomycosis

  2023cites this paper
• Relative impact of traditional vs. newer oral antifungals for dermatophyte toenail onychomycosis: a network meta-analysis study.

  2023cites this paper
• Evaluation of the heat sensitivity of Trichophyton rubrum and Trichophyton interdigitale

  2023cites this paper
• Onychomycosis: Old and New

  2023cites this paper
• Updated Perspectives on the Diagnosis and Management of Onychomycosis

  2022cites this paper
• Updated Perspectives on the Diagnosis and Management of Onychomycosis

  2022cites this paper
• Common Cutaneous Infections: Patient Presentation, Clinical Course, and Treatment Options.

  2021cites this paper
• Race reporting and representation in onychomycosis clinical trials: A systematic review

  2021cites this paper
• Safety of current therapies for onychomycosis

  2020cites this paper
• Onychomycosis: a review

  2020cites this paper
• Rezepte gegen Nagelpilz

  2020cites this paper
• Oral antifungal therapies for toenail onychomycosis: a systematic review with network meta-analysis toenail mycosis: network meta-analysis

  2020cites this paper
• Pediatric nail disorders: a review.

  2020cites this paper
• Monotherapy for toenail onychomycosis: a systematic review and network meta‐analysis

  2019cites this paper
• [Onychomycosis].

  2019cites this paper
• Onychomycosis: Treatment and prevention of recurrence.

  2019cites this paper
• Pharmacotherapy for onychomycosis: new and emerging treatments

  2019cites this paper
• Antifungal Drug Use for Onychomycosis

  2019cites this paper
• Formulation and Development of Antifungal Nail Lacquer Containing Miconazole Nitrate Use in Treatment of Onychomycosis

  2019cites this paper
• Therapy of Skin, Hair and Nail Fungal Infections

  2018cites this paper
• Korean Guideline for the Diagnosis and Treatment of Onychomycosis: Purpose and Process of Algorithm Guideline Development

  2018cites this paper
• Systemic Therapy of Onychomycosis

  2018cites this paper
• Fungal Infections (Onychomycosis, Tinea Pedis, Tinea Cruris, Tinea Capitis, Tinea Manuum, Tinea Corporis, different Candida Infections, and Pityriasis Versicolor) and Mycological Laboratory Analyses

  2018cites this paper
• Global perspectives for the management of onychomycosis

  2018cites this paper
• Oral antifungal medication for toenail onychomycosis.

  2017cites this paper
• New Antifungal Agents and New Formulations Against Dermatophytes

  2017cites this paper
• Is This the Right Drug or the Dose for the Management of Onychomycosis

  2017cites this paper
• FORMULATION AND EVALUATION OF A MEDICATED NAIL LACQUER FOR THE TREATMENT OF ONYCHOMYCOSIS

  2016cites this paper
• Efinaconazole 10% and Tavaborole 5% Penetrate Across Poly-ureaurethane 16%: Results of In Vitro Release Testing and Clinical Implications of Onychodystrophy in Onychomycosis.

  2016cites this paper
• Confirmatory Testing for Onychomycosis-Reply.

  2016cites this paper
• How effective is efinaconazole in the management of onychomycosis?

  2016cites this paper
• Reevaluating the Need for Laboratory Testing in the Treatment of Onychomycosis: Safety and Cost-effectiveness Considerations.

  2016cites this paper
• The Antifungal Drugs Used in Skin Disease

  2016cites this paper
• Confirmatory Testing for Onychomycosis.

  2016cites this paper
• How do we measure efficacy of therapy in onychomycosis: Patient, physician, and regulatory perspectives

  2016cites this paper
• Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.

  2016cites this paper
• Diagnosis and Management of Onychomycosis Perspectives from a Joint Podiatric Medicine-Dermatology Roundtable.

  2016cites this paper
• An investigation into UV-curable gel formulations for topical nail medicines

  2016cites this paper
• The Dermatologist’s Approach to Onychomycosis

  2015cites this paper
• Treatment of Onychomycosis – a Clinical Study

  2015cites this paper
• Efficacy and Safety of Onychomycosis Treatments: An Evidence-Based Overview.

  2015cites this paper
• Management of Onychomycosis in Canada in 2014

  2015cites this paper
• Network Meta-Analysis of Onychomycosis Treatments

  2015cites this paper
• Efficacy of fluconazole at a 400 mg weekly dose for the treatment of onychomycosis.

  2015cites this paper
• Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail

  2015cites this paper
• Formulation and Evaluation of a Medicated Nail Lacquer for the Treatment of Onychomycosis

  2015cites this paper
• British Association of Dermatologists' guidelines for the management of onychomycosis 2014

  2014cites this paper
• Tavaborole for the treatment of onychomycosis

  2014cites this paper
• Placebo cure rates in the treatment of onychomycosis.

  2014cites this paper
• Drug delivery to the nail: therapeutic options and challenges for onychomycosis.

  2014cites this paper
• Oral Therapy for Onychomycosis: An Evidence-Based Review

  2014cites this paper
• Onychomycosis: current and future therapies.

  2014cites this paper
• Therapies for onychomycosis a systematic review and network meta-analysis of mycological cure.

  2014cites this paper
• Diagnosis and management of tinea infections.

  2014cites this paper
• Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment

  2013cites this paper
• Current and emerging options in the treatment of onychomycosis.

  2013cites this paper
• Cost of Treatment for Onychomycosis

  2012cites this paper
• Cost of Treatment for Onychomycosis Data from a 9-Month Observational Study

  2012cites this paper
• An update on treatment of onychomycosis

  2012cites this paper
• Which Antifungal Agent for Onychomycosis?

  2012cites this paper
• Cost Effectiveness of Oral Terbinafine (Lamisil®) Compared with Oral Fluconazole (Diflucan®) in the Treatment of Patients with Toenail Onychomycosis

  2012cites this paper
• Intra-antral application of an anti-fungal agent for recurrent maxillary fungal rhinosinusitis: a case report

  2012cites this paper
• Onychomycosis: Diagnosis and management.

  2011cites this paper
• Systemic drugs in patients with skin diseases.

  2011cites this paper
• Management of Superficial Infections

  2010cites this paper
• Oral Treatments for Toenail Onychomycosis

  2009cites this paper
• Onychomycosis and diabetes

  2009cites this paper
• Toenail Onychomycosis in Diabetic Patients

  2009cites this paper
• Efficacy of Fluconazole for the Treatment of Onychomycosis

  2009cites this paper
• Fungal (Onychomycosis) and Other Infections Involving the Nail Apparatus

  2008cites this paper
• Current management of onychomycosis.

  2008cites this paper
• Review of antifungal therapy and the severity index for assessing onychomycosis: Part I

  2008cites this paper
• Onychomycosis in the Elderly

  2007cites this paper
• Onychomykose

  2007cites this paper
• Toenail onychomycosis: current and future treatment options

  2007influential citation
• Onychomycosis

  2007cites this paper
• Onychomycosis

  2007cites this paper
• Naildex: pilot evaluation of an onychodystrophy severity instrument

  2007cites this paper
• The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.

  2007cites this paper
• Analyse systématique des essais thérapeutiques

  2007cites this paper
• Onychomycosen: wel of niet behandelen en zo ja, hoe?

  2007cites this paper
• Current treatment of onychomycosis.

  2007cites this paper
• Evaluating costs for onychomycosis treatments: a practitioner's perspective.

  2006cites this paper
• Systemic antifungal agents: an update of established and new therapies.

  2006cites this paper
• Therapies for onychomycosis: a review.

  2006cites this paper
• Current use of anti-infectives in dermatology

  2005cites this paper
• Treatment of onychomycosis with oral antifungal agents

  2005cites this paper
• Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.

  2005cites this paper
• Optimal Management of Fungal Infections of the Skin, Hair, and Nails

  2004cites this paper
• Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence.

  2004cites this paper
• The oral antifungal patient.

  2004cites this paper
• Cumulative meta‐analysis of systemic antifungal agents for the treatment of onychomycosis

  2004cites this paper
• [Onychomycosis].

  2004cites this paper
• Cutaneous fungal infections in the elderly.

  2004cites this paper
• The systemic treatment of onychomycosis.

  2004cites this paper
• The use of oral antifungal agents to treat onychomycosis.

  2003influential citation
• Onychomykose

  2003cites this paper
• Pathologie unguéale

  2003cites this paper
• Comparison of efficacy criteria across onychomycosis trials: need for standardization

  2003cites this paper
• Onicomicosis: Revisión del tema

  2003cites this paper